Search Results Search Sort by RelevanceMost Recent In the Literature Jul 2015 Accountable Care Organizations: The First Two Years’ Performance and Directions for the Future Kieran Holzhauer Although there is not yet strong evidence for ACOs’ cost savings, early data on quality improvement seems promising. AMA J Ethics. 2015;17(7):630-636. doi: 10.1001/journalofethics.2015.17.7.nlit1-1507. In the Literature Aug 2013 Why Clinical Oncologists Should Talk about the Price of Cancer Drugs Nancy Berlinger, PhD The cost of lifesaving cancer drugs is a moral concern for oncologists. Virtual Mentor. 2013;15(8):677-680. doi: 10.1001/virtualmentor.2013.15.8.jdsc1-1308.
In the Literature Jul 2015 Accountable Care Organizations: The First Two Years’ Performance and Directions for the Future Kieran Holzhauer Although there is not yet strong evidence for ACOs’ cost savings, early data on quality improvement seems promising. AMA J Ethics. 2015;17(7):630-636. doi: 10.1001/journalofethics.2015.17.7.nlit1-1507.
In the Literature Aug 2013 Why Clinical Oncologists Should Talk about the Price of Cancer Drugs Nancy Berlinger, PhD The cost of lifesaving cancer drugs is a moral concern for oncologists. Virtual Mentor. 2013;15(8):677-680. doi: 10.1001/virtualmentor.2013.15.8.jdsc1-1308.